Latest Asx Compliance News

EMU NL’s securities have been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law. The suspension highlights governance challenges and raises questions about the company’s path to compliance.

Bayan Mining And Minerals Limited’s BMMO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s next steps.

QEM Limited’s trading suspension has been lifted following the release of metallurgical testwork results for its Julia Creek Vanadium and Energy Project, signaling renewed investor interest.

Maronan Metals Limited has had its trading suspension lifted immediately following the release of its Preliminary Economic Assessment, signaling renewed market activity.

TG Metals Limited has clarified that its recent share price and volume spike is linked to Forrestania Resources acquiring a near 10% stake, while metallurgical test results are expected shortly.

Prospech Limited’s PRSO securities have been suspended from trading pending compliance with ASX rules, raising questions about the company’s regulatory standing.

Rapid Critical Metals Limited has had its trading suspension lifted following a capital raising announcement, signaling renewed market activity for the critical metals miner.

MEC Resources has responded to ASX inquiries about unusual trading activity, confirming no undisclosed information but highlighting ongoing Federal Court proceedings involving its investee company.

Xstate Resources Limited has had its trading suspension lifted as it meets key ASX listing requirements, marking a new chapter for the mining company.

Control Bionics Limited has confirmed its compliance with ASX continuous disclosure rules following an inquiry about the timing and content of its financial results announcements.

Camplify Holdings has responded to ASX concerns over a delayed director interest notice, revealing internal process failures and promising tighter compliance measures.

Ramsay Health Care has clarified that its underlying earnings for FY25 aligned closely with market consensus, despite a significant non-cash impairment impacting statutory profits. The company confirms compliance with ASX disclosure rules amid share price volatility.